ChemicalBook > CAS DataBase List > Adintrevimab
Adintrevimab
- Product Name
- Adintrevimab
- CAS No.
- 2516243-54-0
- Chemical Name
- Adintrevimab
- Synonyms
- Adintrevimab;Research Grade Adintrevimab;Research Grade Adintrevimab (DVV00315)
- CBNumber
- CB810617124
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Adintrevimab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Adintrevimab Chemical Properties,Usage,Production
Uses
Adintrevimab (ADG 20) is a human IgG1 monoclonal SARS-CoV (SARS-CoV) antibody. Adintrevimab inhibits SARS-CoV-2 variants and other SARS-like coronaviruses with pandemic potential[1].
in vivo
Adintrevimab (9.25, 55, 333, or 2,000?μg; i.p.; once) provids protection against SARS-CoV-2/WA1/2020 infection in a dose-dependent manner[1].
Adintrevimab (5-25?mg/kg; i.v.; once) provids protection against SARS-CoV-2/WA1/2020 infection in a dose-dependent manner[1].
| Animal Model: | Syrian golden hamsters (5-6-week-old females; 75-125 g) infected with SARS-CoV-2/WA1/2020[1]. |
| Dosage: | 9.25, 55, 333, or 2,000?μg (average range: 0.1 to 20?mg/kg) |
| Administration: | Intraperitoneal injection; single dose |
| Result: | Showed significant reduction in lung viral load and virus-induced lung pathology. |
| Animal Model: | Rhesus macaques (5.6-8.8?years old; 6 females [4.4-6.3?kg] and 6 males [6.1-8.5?kg]) infected with SARS-CoV-2/WA1/2020[1]. |
| Dosage: | 5?mg/kg, 25?mg/kg |
| Administration: | Intravenous injection; single dose |
| Result: | Reduced pulmonary inflammation. |
References
[1] Elizabeth E Zumbrun, et al. Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19. Antimicrob Agents Chemother. 2022 Dec 15;e0135322. DOI:10.1128/aac.01353-22
Adintrevimab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Adintrevimab Suppliers
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 0573-83568680 18057391398
- 3956524501@qq.com
- Country
- China
- ProdList
- 1442
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
- Tel
- 33175446423
- support@antibodysystem.com
- Country
- China
- ProdList
- 6739
- Advantage
- 58
- Tel
- 9785721070
- info@cellsciences.com
- Country
- China
- ProdList
- 6308
- Advantage
- 58
- Tel
- 17765667235
- Country
- CHINA
- ProdList
- 129
- Advantage
- 58
2516243-54-0, AdintrevimabRelated Search:
Retifanlimab
Vepsitamab
Idarucizumab
Research Grade Inotuzumabc (DHD38502)
Adebrelimab
Immunoglobulin G1,anti-(human CD19 (antigen)) (mouse monoclonal B43 g1-chain), disulfide with mouse monoclonal B43 k-chain, dimer, disulfide withprotein PAP (pokeweed antiviral) (9CI)
Olinvacimab
Bapotulimab
Istiratumab
Rulonilimab